Grifols Reshapes Board and Committee Leadership After Director ResignationTip Ranks·1 day ago, 10:17 AMGRFS-4.57%
GRF: Biopharma and IG growth drove higher revenue and margins, supporting 2026 guidanceQuartr·Jul 28 at 01:40 PMGRFS-4.57%
GRF: Revenue up 2.6% and net profit up 28.7%, driven by Biopharma and strong IG growthQuartr·Jul 28 at 10:46 AMGRFS-4.57%
Grifols H1 FY26 profit falls 43.39% to EUR 227.51 million; net sales drop 2.79% to EUR 3.57 billionPUBT·Jul 28 at 10:43 AMGRFS-4.57%
FOXO unit Vector BioSource agrees to buy four Grifols blood collection centers for $3.5 million plus up to $1 million earnoutPUBT·Jul 27 at 03:16 PMGRFS-4.57%FOXOD0.00%
Grifols doses first patient in Phase 3 SIGMA trial of Gamunex-C in secondary immunodeficiencyPUBT·Jul 16 at 07:08 AMGRFS-4.57%
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship ImmunoglobulinsUnusual Whales·Jul 16 at 07:00 AMGRFS-4.57%
Grifols’ Albert Grifols receives EUR 2.89 million in shares via family wealth restructuringPUBT·Jul 3 at 08:23 AMGRFS-4.57%
